CN Patent

CN103788075A — 一种胸苷磷酸化酶抑制剂的结晶形式及其制备方法

Assigned to QILU PHARMACEUTICAL (HAINAN) CO Ltd · Expires 2014-05-14 · 12y expired

What this patent protects

本发明具体公开了5-氯-6-(1-(2-亚氨基吡咯烷基)甲基)尿嘧啶盐酸盐的一种新的结晶形式，并公开了其制备方法；该晶型具有稳定性好、结晶度高、易于制备等优点，能够作为胸苷磷酸化酶抑制剂用于制备治疗结直肠癌的药物。

USPTO Abstract

本发明具体公开了5-氯-6-(1-(2-亚氨基吡咯烷基)甲基)尿嘧啶盐酸盐的一种新的结晶形式，并公开了其制备方法；该晶型具有稳定性好、结晶度高、易于制备等优点，能够作为胸苷磷酸化酶抑制剂用于制备治疗结直肠癌的药物。

Drugs covered by this patent

Patent Metadata

Patent number: CN103788075A
Jurisdiction: CN
Classification: —
Expires: 2014-05-14
Drug substance claim: No
Drug product claim: No
Assignee: QILU PHARMACEUTICAL (HAINAN) CO Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.